Information over the pharmacokinetics of ADB-FUBINACA and AMB-FUBINACA is essential to doc abuse. No knowledge over the distribution of these drugs are available in the literature, but due to their lipophilic character, these drugs are anticipated to extensively bind to plasma proteins. Information on the absorption, metabolism and excretion are he